AzTrials
AzTrials

Acute Kidney InjuryNCT02347930

Establish and Apply the Evaluation System of Ultrasonic Integrated Technology for Prevention and Treatment of Acute Kidney Injury

An observational study of Acute Kidney Injury, run by RenJi Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Establish an integrated evaluation system of ultrasound technology for the prognosis of acute kidney injury, and in order to achieve non-invasive, reliable early diagnosis "gold standard". Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Acute Kidney Injury
What is being tested?
kidney ultrasound
How many people
196 participants
Where
1 siteChina
Study dates
Apr 2014to 30 Dec 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Confirmed acute kidney injury

Who may be able to join

  • Subjects must satisfy the following criteria to be enrolled in the study:
  • Clinical diagnosis of acute or chronic kidney injury
  • Male or female, aged 18-80 years old
  • signed informed consent
  • Patients can breathe in, breathe out and hold their breathe with ease, communication without difficulty.

Who cannot join

  • Potential subjects who meet any of the following criteria will be excluded from participating in the study:
  • Refuse to sign informed consent
  • allergy to micro bubble hexafluoride drug
  • Patients with cardiopulmonary insufficiency, pleural effusion, pulmonary infections
  • Patients with asthma, chronic bronchitis
  • Patients with pregnancy
  • Patients can't cooperate or have a difficulty in breathing in, breathing out or holding their breathe
  • Patients beening diagnosed with End-stage kidney disease.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Department of nephrology , Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, 200127

Other trials in China

About this study

Establish an integrated evaluation system of ultrasound technology for the prognosis of acute kidney injury, and in order to achieve non-invasive, reliable early diagnosis "gold standard". Set up collabration with the expert in National Cheng Kung University Medical Center of Taiwan who did a lot of excellent work in basic research of prevention the progression of acut kidney injury. Study the experience about prevention progression of kidney disease in clinical and basic field. Establish cooperation with the professional in Hong Kong University of Science and Technology. To set up the system of natural products research and assess the Astragalus medicinal value.

Being tested
kidney ultrasound
Keywords
acute kidney injury, ultrasound technology
Medical subject headings
Acute Kidney Injury

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • kidney ultrasoundOther

    kidney ultrasound

Study groups in NCT02347930
Study groupRoleWhat they receive
Confirmed acute kidney injuryConfirmed acute kidney injury
Receives: Other: kidney ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. compare the results of kidney ultrasound with biomarkers of acute kidney injury

    Measured: up to 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2015 (estimated)
  2. Study startApr 2014
  3. Primary completion15 Nov 2017
  4. Study completion30 Dec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
196 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02347930
Sponsor's protocol ID
2014DFT30090
Status last verified
Nov 2023
First submitted
22 Jan 2015
Last updated
27 Nov 2023
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Kidney Injury, run by RenJi Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

compare the results of kidney ultrasound with biomarkers of acute kidney injury (time frame: up to 24 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in